Talquetamab plus Teclistamab in Relapsed or Refractory Multiple MyelomaYaël C. Cohen, María‐Victoria Mateos, Kihyun Kım et al.|New England Journal of Medicine|2025Cited by 96
Teclistamab: Mechanism of action, clinical, and translational scienceYue Guo, Danièle Ouellet, Natalia A. Quijano Cardé et al.|Clinical and Translational Science|2024Cited by 29